Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Proper reconstitution and storage are essential to consistent dosing and predictable side effect patterns
LIFT-AD Trial: Phase 2/3 Termination (September 2024) Despite the ACT-AD disappointment, Athira advanced to a larger phase 2/3 trial called LIFT-AD
availability and use are limited to controlled laboratory investigation, not for human or clinical use
Ultrasonido gstrico El cumplimiento estricto de las pautas de ayuno preoperatorio contina siendo la principal estrategia para la prevencin de la aspiracin de contenido gstrico durante la anestesia
US$ 21.34
US$ 26.83
US$ 20.74
